Detected ·
Colossal Biosciences
——
Colossal Biosciences, the de-extinction startup, is reportedly in talks to raise new funding at a valuation between $20B and $30B, up from its previous $10.2B valuation. The company has begun generating revenue through conservation services, technology commercialization, and biodiversity credits.
- Website
- colossal.com
- linkedin.com/company/colossal
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-22 00:06:00 UTC
- Signal ID
- 494b0026-90d8-4521-a5dd-83f4027bf231
As the API returns it
{
"id": "494b0026-90d8-4521-a5dd-83f4027bf231",
"created_at": "2026-07-22T00:06:00.687760Z",
"company_name": "Colossal Biosciences",
"company_website_url": "colossal.com",
"company_linkedin_url": "https://www.linkedin.com/company/colossal",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Colossal Biosciences, the de-extinction startup, is reportedly in talks to raise new funding at a valuation between $20B and $30B, up from its previous $10.2B valuation. The company has begun generating revenue through conservation services, technology commercialization, and biodiversity credits.*"
}